Company intelligence / Profile preview

Jiangsu Convac Biotechnology

Taizhou, Jiangsu, China

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Jiangsu Convac Biotechnology is a Chinese biopharmaceutical company specializing in the research, development, and manufacturing of human vaccines. Based in the China Medical City in Taizhou, the company focuses on addressing infectious diseases through advanced vaccine technologies, including cell culture and recombinant protein platforms. Its product portfolio and pipeline include vaccines for influenza, rabies, and varicella, as well as next-generation candidates for HPV and shingles. Convac operates large-scale GMP-compliant manufacturing facilities to support the domestic Chinese market and international expansion.

Therapeutic areas: Infectious DiseasesOncology
Modalities: VaccineRecombinant protein
Industry: Biotech

Beyond the preview

Go deeper on Jiangsu Convac Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Convac Biotechnology.

Explore the full profile